ClinicalTrials.Veeva

Menu

Effect-site Concentration of Remifentanil for Double-lumen Tubes Intubation: Airtraq VS Macintosh Laryngoscope

H

Huazhong University of Science and Technology

Status

Completed

Conditions

Hemodynamic Instability
Intubation Complication

Treatments

Device: Airtraq
Device: Macintosh

Study type

Interventional

Funder types

Other

Identifiers

NCT03653910
TJMZK20180713

Details and patient eligibility

About

The 50% effective concentration of remifentanil by target controlled infusion was not determined for inhibiting the haemodynamic response during double-lumen tube (DLT) intubation. Previous study showed that Airtraq videolaryngoscope provided more stable haemodynamics than Macintosh for double-lumen tube intubation. In this study, the investigators will compare the 50% effective concentration of remifentanil between Airtraq videolaryngoscope and Macintosh laryngoscope for inhibiting haemodynamic responses during DLT intubation.

Full description

Dixon "up-and-down" method was used to determine 50% effective concentration of remifentanil by target controlled infusion for inhibiting the haemodynamic responses during DLT intubation with Airtraq videolaryngoscope or Macintosh laryngoscope.

Enrollment

62 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criterias:

  1. American Society of Anesthesiologists physical status of I-II
  2. Patients aged 18-65 years
  3. BMI 18-35 kg/m2
  4. Elective pulmonary surgery under general anesthesia to double-lumen tubes intubation
  5. Mallampati classifications Ⅰ-Ⅱ

Exclusion Criterias:

  1. Emergency operation
  2. Anticipated difficult airway or history of intubation difficulties
  3. Be allergic to any of the drugs used in the experiment, or have a history of drug allergy
  4. Preoperative use of analgesic, sedative and other drugs
  5. Uncontrolled hypertension and heart disease
  6. Have a history of heavy smoking and alcohol abuse, serious drug abuse, and severe systemic infections
  7. There are severe mental and nervous system symptoms, and patients cannot cooperate with the study, such as language comprehension disorder, mental illness, etc
  8. Other clinical trials were conducted within 3 months prior to inclusion in the study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

62 participants in 2 patient groups

Airtraq
Experimental group
Description:
Patients received DLT intubation by Airtraq videolarygoscope
Treatment:
Device: Airtraq
Macintosh
Active Comparator group
Description:
Patients received DLT intubation by Macintosh laryngoscope
Treatment:
Device: Macintosh

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems